Wave Life Sciences Ltd. (WVE) Stock Overview
Explore Wave Life Sciences Ltd.’s financial performance, market position, analyst ratings, and future outlook.
Wave Life Sciences Ltd. (WVE)
Key Financials
Key Financials
Market Cap
1B
P/E Ratio
-4.89
EPS (TTM)
$-1.06
ROE
-0.50%
WVE Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Wave Life Sciences Ltd. (NASDAQ: WVE) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Wave Life Sciences Ltd.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of WVE on the NASDAQ shows an RSI of 43.67, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $12.94 for the NASDAQ listing.
Key metrics behind Wave Life Sciences Ltd.'s NASDAQ-traded stock include a P/E ratio of -4.89 and a market capitalization of 1B. Combined with our AI analysis, these give both institutional and retail investors a clear view of WVE on the NASDAQ.